CRC助理

Chinese biomedical research company established in August 2018 in the formulation accelerator of the Nanjing Jiangbei New Area biomedical valley, Jiangsu. Acts as the operating entity of the Nanjing Translational Institute of Molecular Medicine of Peking University, a joint research translation base built by the Institute of Molecular Medicine of Peking University together with the Nanjing Jiangbei New Area and the Nanjing biomedical valley. Led by Peking University director Xiao Ruiping and academician Cheng Heping, it works on two lines - high end biomedical imaging equipment and innovative drugs for major diseases - and offers high throughput industrialised high resolution brain imaging research services and preclinical testing services for drug development, with a team including one academician, three National Science Fund for Distinguished Young Scholars recipients and five Excellent Young Scientists.